INSTRUCTIONS REGISTRATION
Registrants must submit the documents outlined below.
(1) Registration Form (pages 2-5)
The form must be signed by the registrant and countersigned by an official capable of legally binding the institution (e.g. president, vice-president, dean, or provost, but NOT a department chairman).
(2) Biographical Sketch (page 6-7)
Attach a Biographical Sketch that includes a listing of five recent, representative publications, or a brief curriculum vitae. A Biographical Sketch from a recent NIH grant proposal may be submitted instead.
Provide a FedEx (or other shipping company) account number. The NIH Tetramer Facility will not bill requesters for shipping charges; you MUST provide an account number so that your shipping company can bill you. Your carrier must be able to ship packages containing ice and/or dry ice. Because of changes in the airline industry, scientists outside of the US must arrange for prepayment of shipping charges with their carrier; reagents will not be shipped collect.
MAIL your completed registration forms to:
NIH Tetramer Facility
Thermo Fisher BioServices
20301 Century Boulevard, Building 6, Suite 200
Germantown, MD 20874
TEL: (240) 686-4740
Email: Tetramer@thermofisher.com
NOTE: Faxed forms or forms with out the original signatures will not be accepted.
![]()
(Please type)
Name |
|
|---|---|
Title |
|
Telephone |
|
Shipping Company |
|
Institution |
|
FAX |
|
Shipping Company Account Number |
Full Shipping Address (Please write/type the address exactly as it should appear on a mailing label. Reagents cannot be shipped to a post office box.):
Research Support, if applicable (specify types and grant/award numbers):
NIH Intramural Research |
|
|---|---|
Other Federal Funding |
|
Private Foundation |
|
Industry |
|
NIH Extramural Research |
|
State Funding |
|
Funding Outside of United States |
|
Other |
The MATERIAL ("tetramers, monomers and other novel ligands provided by the tetramer facility") and its use is claimed in U.S. Patent 5,635,363 and corresponding foreign patents relating to "Detection, Enumeration, Purification of Antigen-Specific T Cells." The rights to these patents are assigned to Stanford University and licensed exclusively to Beckman Coulter, Inc. (BCI). Stanford has granted the US Government a nonexclusive license under 35 U.S.C. § 202 (c)(4). BCI has granted NIH the right to provide the Recipient with a sublicense, and NIH hereby grants Recipient a sublicense to use the Material under the following conditions.
Requester's Institution acting through its investigator ("Recipient") agrees that, when the US Government is providing financial support to the Recipient for a research or clinical development activity in which the Material will be used, the Recipient Institution will use the materials provided by the NIH Tetramer Facility in activities only within the scope of the US Government funding agreement.
Recipient agrees that, when the US Government is not providing any financial support to the Recipient Institution for a research or clinical development activity in which the Material will be used, the Recipient will use the Material for its internal noncommercial research purposes only. The Material will not be used for any commercial purpose, for use in man, or for the direct benefit of any for-profit institution. Accordingly and without limitation, the Recipient is not permitted under this Material Transfer Agreement to use any Material to test compounds for any commercial purpose, for use in man, or for the direct benefit of any for-profit institution or use the Materials for the production of products for any commercial purpose or for the direct benefit of any for-profit institution. For purposes of this agreement, the term "commercial purposes" shall be broadly construed to mean any purpose wherein consideration, in any form, is received.
The Recipient is notified by NIH of the existence of Stanford Patent Rights and the exclusive license thereof to BCI, and that the restrictions set forth in the two paragraphs above shall exist only during the term of the Stanford Patent Rights.
The Recipient agrees not to transfer the Material to any third parties.
With respect to further license rights under the Stanford Patent Rights, the Recipient should contact:
Elsa Burgess
Director, Business Development
Beckman Coulter Inc.
11800 SW 147th Ave M/S 32-C08
Miami, FL 33196-9015
Office Telephone: (305) 380-3166
Cell phone: (786) 423-8569
E-mail: elsa.burgess@coulter.com
Requester's Institution acting through its investigator ("Recipient") agrees that any MATERIAL delivered pursuant to this Agreement is understood to be experimental in nature and may have hazardous properties. The United States Government, ThermoFisher BioServices, and their Suppliers and contributors of reagents ("Providers") MAKE NO REPRESENTATIONS AND EXTEND NO WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED. THERE ARE NO EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Unless prohibited by federal and/or state law, Recipient assumes all liability for claims for damages against it by third parties which may arise from the use, storage, or disposal of the MATERIAL except that, to the extent permitted by federal and/or state law, the Providers shall be liable to the Recipient when the damage is caused by the gross negligence or willful misconduct of the Providers. The legal process for filing and adjudicating such claims against the Recipient or Providers will be subject to all applicable state and/or federal laws.
Recipient shall directly supervise all users of the MATERIAL ("tetramers, monomers and other novel ligands provided by the tetramer facility") and shall assume responsibility for assuring that those users are cognizant of and comply with safety standards and good laboratory practices.
None of the MATERIAL provided by the NIH Tetramer Facility nor any derivatives of said MATERIAL will be used in humans or for any clinical diagnosis or treatment decisions. The intent of these conditions is to protect both the rights and the welfare of human subjects (in compliance with Title 45 Code of Federal Regulation Part 46), and to protect the NIH Tetramer Facility, since the MATERIAL is not produced under GMP conditions.
Recipient agrees that MATERIAL provided by the NIH Tetramer Facility and any Derivatives of said Material will be used in animals only as described in: Public Health Service Policy on Humane Care and Use of Laboratory Animals, March, 1996, or the latest version thereof (copies may be obtained from the NIH Division of Animal Welfare, TEL: 301-496-7163, or the US Government Printing Office, Publication No. 249-260).
Recipient agrees to assume the costs of shipping MATERIAL by providing an overnight carrier shipping account number, or by making arrangements for prepaid shipments. No shipments will be made until Recipient's proposed shipping arrangements are accepted by the NIH Tetramer Facility.
Recipient agrees to acknowledge the NIH Tetramer Facility in all publications and presentations of studies utilizing Materials supplied by the NIH Tetramer Facility. The suggested form for acknowledgments is: "The following tetramer was obtained (for premade class II MHC tetramers only, insert: from the Virginia Mason Research Center) through the NIH Tetramer Facility: (tetramer name)."
Recipient agrees to provide the NIH Tetramer Facility with copies of all abstracts and publications resulting from use of the MATERIAL.
Recipient agrees that the NIH Tetramer Facility may publish successfully produced tetramers that were requested by Recipient to the NIH Tetramer Facility's website ("Website"). "Publish" means listing of the MHC allele, peptide sequence, parent protein from which the peptide was derived, and the organism from which the peptide/protein is derived at any time after such tetramers are sent to Recipient. Recipient may request that none of their requested tetramers be published to the Website for a period of six (6) months after delivery by checking the appropriate option below:
![]()
*Officer of Recipient's Institution or Company (Signature) |
Recipient (Signature) |
Printed Name |
Printed Name |
Title |
Title |
Institution |
Institution |
Date |
Date |
*The officer cosigning above must be capable of legally binding the Institution.
![]()
![]()
This form, or a Biographical Sketch from a recent NIH grant proposal, may be
submitted in lieu of a curriculum vitae.
Name:
Position/Title:
Education: Begin with Baccalaureate or other initial professional education and include postdoctoral training.
INSTITUTION AND LOCATION |
DEGREE |
YEAR CONFERRED |
FIELD OF STUDY |
|---|---|---|---|
Research and Professional Experience: Concluding with your present position, please list, in chronological order, your three most recent professional positions.
EMPLOYER |
TITLE |
DATES OF EMPLOYMENT |
|---|---|---|
Publications: Please list up to five recent representative publications.
1. |
2. |
3. |
4. |
5. |
![]()